🇺🇸 FDA
Patent

US 11135236

Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity

granted A61KA61K31/192A61K31/196

Quick answer

US patent 11135236 (Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity) held by Northwestern University expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/192, A61K31/196, A61K31/381, A61K31/415